MCKERSSON INFORMATION SOLUTIONS, INC. v. Bridge Medical, Inc.

434 F. Supp. 2d 810, 2006 U.S. Dist. LEXIS 38409, 2006 WL 1530233
CourtDistrict Court, E.D. California
DecidedJune 5, 2006
DocketCIV. S-02-2669 FCD KJM
StatusPublished
Cited by2 cases

This text of 434 F. Supp. 2d 810 (MCKERSSON INFORMATION SOLUTIONS, INC. v. Bridge Medical, Inc.) is published on Counsel Stack Legal Research, covering District Court, E.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
MCKERSSON INFORMATION SOLUTIONS, INC. v. Bridge Medical, Inc., 434 F. Supp. 2d 810, 2006 U.S. Dist. LEXIS 38409, 2006 WL 1530233 (E.D. Cal. 2006).

Opinion

*811 AMENDED MEMORANDUM AND ORDER 1

DAMRELL, District Judge.

At the April 11, 2006 hearing on the parties’ motions in limine, the court took two of defendant Bridge Medical, Inc.’s (“Bridge”) motions under submission: (1) Bridge’s motion in limine # 5 to exclude evidence and testimony regarding its advice of counsel (Docket # 588) and (2) Bridge’s motion in limine # 6 to strike ten witnesses on plaintiff McKesson Information Solutions, Inc.’s (“McKesson”) witness list (Docket # 589). 2 By this order, the court issues its decision on those motions.

First, regarding Bridge’s motion in limine # 5, Bridge has asserted the attorney-client privilege over an opinion of counsel it received regarding the '716 patent; Bridge does not intend to rely on said opinion to defend against McKesson’s charge of willful infringement. As such, by this motion, Bridge seeks to preclude any evidence or testimony regarding its assertion of the attorney-client privilege over its opinion of counsel. In support, Bridge relies on Knorr-Bremse Systeme Fuer Nutzfahrzeuge GmbH v. Dana Corp., 883 F.3d 1337 (Fed.Cir.2004) wherein the Federal Circuit held, overturning prior precedent, that: “the assertion of attorney-client and/or work-product privilege and the withholding of the advice of counsel shall no longer entail an adverse inference as to the nature of the advice” that was given. Id. at 1345. The court similarly held with respect to the absence of an opinion of counsel that: “the failure to obtain an exculpatory opinion of counsel shall no longer provide an adverse inference or evidentiary presumption that such an opinion would have been unfavorable” had it been given. Id. at 1346.

The parties agree that pursuant to Knorr, McKesson cannot argue to the jury that it should infer that the opinion received by Bridge was unfavorable. However, the question before the court is whether McKesson may nonetheless inform the jury that Bridge asserted the attorney-client privilege over the opinion it received regarding McKesson’s patent. The Federal Court in Knorr expressly declined to decide whether the jury “can or should be told whether or not counsel was consulted (albeit without any inference as to the nature of the advice received) as part of the totality of the circumstances relevant to the question of willful infringement.” Id. at 1347. Rather, the court held that “[tjoday we resolve only the question of whether adverse inferences of unfavorable opinions can be drawn, and hold they can not.” Id.

Subsequent cases applying Knorr have held in the context of an absence of an opinion of counsel, that the jury may consider that fact in its willful infringement analysis (without inferences about the nature of any potential opinion). See e.g. IMX, Inc. v. Lendingtree, LLC, 2006 WL *812 38918, *1 (D.Del. January 6, 2006) (holding that “fact that no opinion of counsel on the issue of infringement was'acquired by defendant may be considered by the trier of fact in its willful infringement analysis”); Third Wave Technol. v. Stratagene Corp., 405 F.Supp.2d 991, 1016-17 (W.D.Wis. 2005) (holding that Knorr “did not say that it was improper for a jury to infer from infringer’s failure to consult counsel that the infringer had no prior knowledge of its opponent’s patents or that it had not acted properly in other respects”).

These cases, however, are distinguishable on the facts because, here, Bridge consulted counsel and received an opinion but has chosen to assert the attorney-client privilege. The court finds that this distinction requires a different result than in Third Wave and IMX. Unlike those cases, any possible inference that the jury could draw from knowing that Bridge received an opinion of counsel, but refuses to reveal it under a claim of privilege, would run directly afoul of the rationale of Knorr. 383 F.3d at 1344 (“the inference that withheld opinions are adverse to the client’s actions can distort the attorney client relationship, in derogation of the foundations of that relationship”). The Federal Circuit explained in Knorr that there should be no “special rule affecting attorney-client relationships in patent cases” because

[tjhere should be no risk of liability in disclosures to and from counsel in patent matters; such risk can intrude upon full communication and ultimately the public interest in encouraging open and confident relationships between client and attorney.

Id.

While the court acknowledges that McKesson may well be prejudiced by the preclusion of evidence that Bridge obtained an opinion of counsel while asserting the attorney-client privilege, the court must also consider that Bridge would be prejudiced by the admission of such evidence while asserting the privilege. Ultimately, the court must balance the parties’ respective interests, considering the dictates of Knorr and its emphasis on the sanctity of the privilege. “The attorney-client privilege protects ‘interests and relationships which ... are regarded as of sufficient social importance to justify some sacrifice of availability of evidence relevant to the administration of justice.’ ” Id. (citation omitted.) Indeed, how can the court honor the shield of the attorney-client privilege and then allow McKesson to use it as a sword to prove its case?

Were the court to permit such evidence, even with a cautionary instruction imposing Knorr’s limitations (of no adverse inference), the jury would nevertheless be left to speculate why Bridge would not reveal its counsel’s opinion. It is inescapable that the jury would likely conclude that Bridge received an unfavorable opinion, otherwise Bridge would reveal it. This is precisely the negative inference Knorr prohibits.

Accordingly, Bridge’s motion in limine # 5 is GRANTED. McKesson is precluded, in all respects, from introducing evidence or testimony pertaining to Bridge’s assertion of the attorney client privilege over the opinion of counsel it received regarding the '716 patent.

Next, regarding Bridge’s motion in limine # 6, with the exception of witness George Putnam, 3 the subject witnesses, *813 while not disclosed by McKesson in its Federal Rule of Civil Procedure, Rule 26 disclosures, were otherwise made known to Bridge during the discovery process. Fed.R.Civ.P. 26(e)(1). Indeed, with the exception of Putnam, all of the challenged witnesses were identified in documents produced by both Bridge and McKesson during discovery.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
434 F. Supp. 2d 810, 2006 U.S. Dist. LEXIS 38409, 2006 WL 1530233, Counsel Stack Legal Research, https://law.counselstack.com/opinion/mckersson-information-solutions-inc-v-bridge-medical-inc-caed-2006.